These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Potential Association Between Acute Colonic Pseudo-Obstruction (Ogilvie Syndrome) and Oral Nimodipine: Report of Two Cases. De Jesus O; Sánchez Jiménez J; Vicenty JC Cureus; 2022 Aug; 14(8):e28039. PubMed ID: 36120238 [TBL] [Abstract][Full Text] [Related]
3. Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage. Carlson AP; Hänggi D; Wong GK; Etminan N; Mayer SA; Aldrich F; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Bleck T; Grubb R; Miller M; Suarez JI; Proskin HM; Macdonald RL; Stroke; 2020 Apr; 51(4):1142-1149. PubMed ID: 32138631 [TBL] [Abstract][Full Text] [Related]
4. Incidence of Arterial Hypotension in Patients Receiving Peroral or Continuous Intra-arterial Nimodipine After Aneurysmal or Perimesencephalic Subarachnoid Hemorrhage. Kieninger M; Gruber M; Knott I; Dettmer K; Oefner PJ; Bele S; Wendl C; Tuemmler S; Graf B; Eissnert C Neurocrit Care; 2019 Aug; 31(1):32-39. PubMed ID: 30725331 [TBL] [Abstract][Full Text] [Related]
5. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884 [TBL] [Abstract][Full Text] [Related]
6. Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]. Hänggi D; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Macdonald RL; Neurocrit Care; 2019 Feb; 30(1):88-97. PubMed ID: 30014184 [TBL] [Abstract][Full Text] [Related]
7. Accuracy of nimodipine gel extraction. Oyler DR; Stump SE; Cook AM Neurocrit Care; 2015 Feb; 22(1):89-92. PubMed ID: 25124105 [TBL] [Abstract][Full Text] [Related]
8. Safety and Clinical Effects of Switching From Intravenous to Oral Nimodipine Administration in Aneurysmal Subarachnoid Hemorrhage. Göttsche J; Schweingruber N; Groth JC; Gerloff C; Westphal M; Czorlich P Front Neurol; 2021; 12():748413. PubMed ID: 34867733 [No Abstract] [Full Text] [Related]
9. NEWTON-2 Cisternal (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage): A Phase 2, Multicenter, Randomized, Open-Label Safety Study of Intracisternal EG-1962 in Aneurysmal Subarachnoid Hemorrhage. Macdonald RL; Hänggi D; Ko NU; Darsaut TE; Carlson AP; Wong GK; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Ng D; Strange P; Bleck T; Grubb R; Suarez JI Neurosurgery; 2020 Dec; 88(1):E13-E26. PubMed ID: 32985652 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials. Dayyani M; Sadeghirad B; Grotta JC; Zabihyan S; Ahmadvand S; Wang Y; Guyatt GH; Amin-Hanjani S Stroke; 2022 Jun; 53(6):1993-2005. PubMed ID: 35354302 [TBL] [Abstract][Full Text] [Related]
11. Incidence of and factors associated with manipulation of nimodipine dosage in patients with aneurysmal subarachnoid hemorrhage. MacKenzie M; Gorman SK; Doucette S; Green R Can J Hosp Pharm; 2014 Sep; 67(5):358-65. PubMed ID: 25364018 [TBL] [Abstract][Full Text] [Related]
12. Outcome of Oral and Intra-arterial Nimodipine Administration After Aneurysmal Subarachnoid Haemorrhage - A Single-centre Study. Ehrlich G; Kirschning T; Wenz H; Hegewald AA; Neumaier-Probst E; Seiz-Rosenhagen M In Vivo; 2019; 33(6):1967-1975. PubMed ID: 31662526 [TBL] [Abstract][Full Text] [Related]
13. Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage]). Hänggi D; Etminan N; Aldrich F; Steiger HJ; Mayer SA; Diringer MN; Hoh BL; Mocco J; Faleck HJ; Macdonald RL; Stroke; 2017 Jan; 48(1):145-151. PubMed ID: 27932607 [TBL] [Abstract][Full Text] [Related]